RankAlpha logo
Back to Rankings

AMGN

AmgenD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Bull: successful late-stage readouts, stable biologics demand, and continued buybacks drive EPS and multiple expansion toward the analyst high.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +1.7.
What can break
Biosimilar competition driving pricing/volume erosion
Momentum
74
Value
63
Sentiment
42
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $333.98 · Bull $425.00 · Bear $180.00Analysis 2026-01-23; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-23 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-08

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $396.46
Why
Momentum74 · Δ7d -4.0
Value63 · Δ7d -0.0
Sentiment42 · Δ7d +1.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Sentiment remains the lead driver in the composite, 7D delta +1.7.

Contradictions & invalidation

  • Biosimilar competition driving pricing/volume erosion
  • Disappointing capital-allocation actions or integration outcomes
  • Bear: trial failures, accelerated biosimilar erosion, or adverse pricing/regulatory moves compress revenue and push valuation toward analyst lows.

Catalyst clock

2026-04-23

FY2025 Q4 earnings & guidance

Lead driver: Sentiment · See AI snapshot
Momentum
74
9% active weight
Current posture
7d trendSoftening
Δ7d
-4.0
Δ21d
-12.8
Value
63
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.7
Sentiment
42
62% active weight
Current posture
7d trendImproving
Δ7d
+1.7
Δ21d
-4.1
Why this grade

Composite grade D. Momentum 73.6 / Value 62.9 / Sentiment 42.3

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-23. Scenario method

B+
Bull case
20%
Probability
Target price
$425.00
Analysis reference price unavailable
Analysis 2026-01-23 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$333.98
Analysis reference price unavailable
Analysis 2026-01-23 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$180.00
Analysis reference price unavailable
Analysis 2026-01-23 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$226.73B
Beta
0.46
Shares Out
540.63M
P/E (TTM)
24.8
P/S (TTM)
4.80
P/FCF (TTM)
26.60
Rev YoY
+9.8%
EPS YoY
+64.9%
Gross Margin
+72.7%
Op Margin
+33.3%
Net Debt
$46.31B
Current Ratio
1.37
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data